BVATX
Price
$10.95
Change
+$0.01 (+0.09%)
Updated
Aug 5 closing price
Net Assets
34.96M
UVABX
Price
$10.02
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Net Assets
460.7M
Interact to see
Advertisement

BVATX vs UVABX

Header iconBVATX vs UVABX Comparison
Open Charts BVATX vs UVABXBanner chart's image
Sterling Capital VA Interm Tax-Free I
Price$10.95
Change+$0.01 (+0.09%)
VolumeN/A
Net Assets34.96M
Victory VA Bond
Price$10.02
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets460.7M
BVATX vs UVABX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BVATX vs. UVABX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVATX is a Buy and UVABX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UVABX has more cash in the bank: 461M vs. BVATX (35M). UVABX pays higher dividends than BVATX: UVABX (2.97) vs BVATX (2.59). BVATX was incepted earlier than UVABX: BVATX (26 years) vs UVABX (15 years). UVABX (0.91) is less costly to investors than BVATX (0.62). BVATX is a more actively managed with annual turnover of: 20.54 vs. UVABX (6.00). UVABX has a lower initial minimum investment than BVATX: UVABX (2500) vs BVATX (1000000). BVATX annual gain was more profitable for investors over the last year : 0.31 vs. UVABX (-3.64). BVATX return over 5 years is better than : -1.92 vs. UVABX (-2.38).
BVATXUVABXBVATX / UVABX
Total Expense Ratio0.620.8077%
Annual Report Gross Expense Ratio0.620.9168%
Fund Existence26 years15 years-
Gain YTD0.986-2.449-40%
Front LoadN/A2%-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets35M461M8%
Annual Yield % from dividends2.592.9787%
Returns for 1 year0.31-3.64-9%
Returns for 3 years3.732.34159%
Returns for 5 years-1.92-2.3881%
Returns for 10 years13.274.00332%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANTX1.060.01
+0.95%
AN2 Therapeutics
CSX35.650.19
+0.54%
CSX Corp
HCI140.200.71
+0.51%
HCI Group
SFST41.000.07
+0.17%
Southern First Bancshares
SSL4.97N/A
N/A
Sasol Limited